secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUCELL CORP /DE/ (ICCC)
CIK:        0000811641
Form:       8-K
Filed at:   2026-02-02T23:59:59+00:00
Accession:  0001437749-26-002685
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmuCell enters new employment agreements with CFO, SVP; grants stock options
-----------------------------------------------------------------------------

- CFO Fiori base salary $315k, target bonus 50% of base, option for 120k shares at $6.26.
- SVP Brockmann base salary $300k, same bonus structure, option for 100k shares.
- CEO te Boekhorst gets performance-based option for 110k shares, vests only if 4-quarter net operating income ≥ 300% of FY2025 audited NOI.
- Options vest in 3 equal annual installments starting Jan 2027, expire 10 years, subject to change-of-control acceleration.
- Effective January 27, 2026; agreements include clawback and severance provisions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811641/000143774926002685/0001437749-26-002685-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811641/000143774926002685/iccc20260202_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-002685

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer